These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 17508274)
21. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience. Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319 [TBL] [Abstract][Full Text] [Related]
22. Genetic susceptibility to breast cancer. Bradbury AR; Olopade OI Rev Endocr Metab Disord; 2007 Sep; 8(3):255-67. PubMed ID: 17508290 [TBL] [Abstract][Full Text] [Related]
23. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Hampel H; Bennett RL; Buchanan A; Pearlman R; Wiesner GL; Genet Med; 2015 Jan; 17(1):70-87. PubMed ID: 25394175 [TBL] [Abstract][Full Text] [Related]
24. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341 [TBL] [Abstract][Full Text] [Related]
25. Impact of Implementing B-RST Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475 [TBL] [Abstract][Full Text] [Related]
26. Prenatal genetic counseling practices regarding recommendations for cancer genetic counseling: A retrospective chart review from two academic institutions. Saba LF; Sullivan CM; Solomon T; Huguenard S; Nassef SA J Genet Couns; 2022 Oct; 31(5):1062-1070. PubMed ID: 35434961 [TBL] [Abstract][Full Text] [Related]
27. Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. Crawford B; Adams SB; Sittler T; van den Akker J; Chan S; Leitner O; Ryan L; Gil E; van 't Veer L Breast Cancer Res Treat; 2017 Jun; 163(2):383-390. PubMed ID: 28281021 [TBL] [Abstract][Full Text] [Related]
28. A Relational Approach to Genetic Counseling for Hereditary Breast and Ovarian Cancer. Forbes Shepherd R; Browne TK; Warwick L J Genet Couns; 2017 Apr; 26(2):283-299. PubMed ID: 27761849 [TBL] [Abstract][Full Text] [Related]
29. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial. de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM Trials; 2014 Mar; 15():86. PubMed ID: 24649895 [TBL] [Abstract][Full Text] [Related]
30. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195 [TBL] [Abstract][Full Text] [Related]
31. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example. Prucka SK; McIlvried DE; Korf BR Med Princ Pract; 2008; 17(3):173-89. PubMed ID: 18408385 [TBL] [Abstract][Full Text] [Related]
32. Cancer Genetic Counseling and Testing in an Era of Rapid Change. Hooker GW; Clemens KR; Quillin J; Vogel Postula KJ; Summerour P; Nagy R; Buchanan AH J Genet Couns; 2017 Dec; 26(6):1244-1253. PubMed ID: 28434142 [TBL] [Abstract][Full Text] [Related]
33. An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. Lynch HT; Watson P; Tinley S; Snyder C; Durham C; Lynch J; Kirnarsky Y; Serova O; Lenoir G; Lerman C; Narod SA Cancer Genet Cytogenet; 1999 Mar; 109(2):91-8. PubMed ID: 10087939 [TBL] [Abstract][Full Text] [Related]
34. Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology. Malhotra H; Kowtal P; Mehra N; Pramank R; Sarin R; Rajkumar T; Gupta S; Bapna A; Bhattacharyya GS; Gupta S; Maheshwari A; Mannan AU; Reddy Kundur R; Sekhon R; Singhal M; Smruti BK; Sp S; Suryavanshi M; Verma A JCO Glob Oncol; 2020 Jul; 6():991-1008. PubMed ID: 32628584 [TBL] [Abstract][Full Text] [Related]
35. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Pasacreta JV Cancer Invest; 2003; 21(4):588-623. PubMed ID: 14533449 [TBL] [Abstract][Full Text] [Related]
36. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters. Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372 [TBL] [Abstract][Full Text] [Related]
38. Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome. Obstet Gynecol; 2017 Sep; 130(3):e110-e126. PubMed ID: 28832484 [TBL] [Abstract][Full Text] [Related]
39. No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer. Jacobson M; Bernardini M; Sobel ML; Kim RH; McCuaig J; Allen L J Obstet Gynaecol Can; 2018 Nov; 40(11):1497-1510. PubMed ID: 30473125 [TBL] [Abstract][Full Text] [Related]
40. Counseling the at risk patient in the BRCA1 and BRCA2 Era. Barnes-Kedar IM; Plon SE Obstet Gynecol Clin North Am; 2002 Jun; 29(2):341-66, vii. PubMed ID: 12108833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]